Characterization of immune complexes formed by merozoites and antibodies from malaria-exposed individuals[4], and results from seroepidemiological studies support the development of the major merozoite surface protein-1 (MSP1) as a vaccine candidate[5-7]. The gene discussed is ATAD1; the disease is malaria.